KUALA LUMPUR, Dec 9 (Bernama) -- The Sabin Vaccine Institute has awarded 2022 Albert B. Sabin Gold Medal to vaccine research leader Kathrin U. Jansen, PhD, and the Rising Star to immunologist Kizzmekia Corbett, PhD.
“The two extraordinary scientists have been honoured for their breakthrough vaccine research that changed the course of the COVID-19 pandemic, advanced public health, and saved countless lives,” it said in a statement.
The Gold Medal, now in its 29th year, is Sabin’s highest scientific honour, given annually to a distinguished member of the global health community who has made exceptional contributions to vaccinology or a complementary field.
“We are delighted to recognise Dr Jansen with our Gold Medal award for her commitment to furthering vaccines and tackling tough scientific challenges in the interest of benefitting humanity and saving lives.
“Sabin is delighted to name Dr Corbett this year’s Rising Star. Her contributions to vaccine development are matched only by her dedication to shoring up vaccine confidence, especially among skeptics,” said Sabin’s chief executive officer, Amy Finan.
Dr Jansen was selected for her nearly three decades of commitment to advancing vaccine research and development (R&D) for a range of challenging diseases from COVID-19 to HPV and pneumonia, all of which afflict adults and children in low-and middle-income countries with already fragile health care systems.
Meanwhile, Sabin’s Rising Star Dr Corbett is an assistant professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health.
A viral immunologist by training, Dr Corbett works to advance vaccine development for pandemic preparedness and to build public confidence in vaccines, particularly among communities of colour facing health disparities.
The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation.
-- BERNAMA
No comments:
Post a Comment